Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.895 USD | -0.13% | -6.02% | +4.28% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.28% | 444M | |
+9.89% | 115B | |
+11.92% | 106B | |
-2.59% | 21.96B | |
-12.52% | 21.87B | |
-5.29% | 19.21B | |
-3.85% | 18.08B | |
-38.57% | 17.71B | |
+7.05% | 14.32B | |
+35.74% | 12.42B |
- Stock Market
- Equities
- FATE Stock
- News Fate Therapeutics, Inc.
- Wedbush Adjusts Fate Therapeutics' Price Target to $5 From $7, Keeps Neutral Rating